Colombia-Based Healthcare Startup IPSUM Secures $200K To Fund Tropical Disease Clinical Trials In Santa Marta
This is an excerpt from an article in MedGadget. Read the full article here.
IPSUM Clinical Corp, a healthcare startup focusing on clinical services in Latin America, has secured $200K in investments that it will use to build clinical research sites all over the region, with a focus in Colombia. IPSUM – which focuses on oncology and tropical diseases – has already upgraded its first clinical trial site in the Colombian coastal city of Santa Marta. Its first project will be testing treatment for the tropical parasitic disease “Chagas,” which is transmitted by insects. This illness is rife among children, especially impacting those belonging to the local indigenous population.
“By basing our research clinics in these rural disease-stricken areas, we can combine our research programs with local affected population,” explains Dr. Laureano Mestra, Chief Medical Officer of IPSUM. “In this way, we can offer the benefits of experimental drugs for conditions that usually have limited options for treatment.
Colombia is the perfect example of a lagging clinical research services industry, as the country has a population of nearly 50 million people but houses less than 150 active clinical trial sites.”[Read More]